Liver Biopsy
12
0
0
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
16.7%
2 terminated out of 12 trials
66.7%
-19.8% vs benchmark
17%
2 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
19G FNB Needle vs 22G FNB Needle for EUS-Guided Liver Biopsy
Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion
Novel Guidance Device for Image Fusion and Needle Guidance in Lung, Liver or Kidney Biopsy
Efficacy and Safety of Percutaneous Liver Biopsy With Needle Tract Plugging on Outpatient Basis
Endoscopic Ultrasound vs Percutaneous Route for Liver Biopsy
Liver Biopsy Using a 19 Gauge Fine Needle Biopsy Needle
Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case
Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta
Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses
Identification of Liver Tumours Using BIP - Biopsy System
Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis